ArticleMultiple sclerosis and related disorders2022

The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome.

Erin E Longbrake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.